592 related articles for article (PubMed ID: 15878737)
41. Epo-induced hemoglobinization of SKT6 cells is mediated by minimal cytoplasmic domains of the Epo or prolactin receptors without modulation of GATA-1 or EKLF.
Reese TT; Gregory RC; Sharlow ER; Pacifici RE; Crouse JA; Todokoro K; Wojchowski DM
Growth Factors; 1997; 14(2-3):161-76. PubMed ID: 9255607
[TBL] [Abstract][Full Text] [Related]
42. Mouse model of congenital polycythemia: Homologous replacement of murine gene by mutant human erythropoietin receptor gene.
Divoky V; Liu Z; Ryan TM; Prchal JF; Townes TM; Prchal JT
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):986-91. PubMed ID: 11158582
[TBL] [Abstract][Full Text] [Related]
43. Low doses of EPO activate MAP kinases but not JAK2-STAT5 in rat vascular smooth muscle cells.
Ammarguellat F; Llovera M; Kelly PA; Goffin V
Biochem Biophys Res Commun; 2001 Jun; 284(4):1031-8. PubMed ID: 11409898
[TBL] [Abstract][Full Text] [Related]
44. STAT5 activation correlates with erythropoietin receptor-mediated erythroid differentiation of an erythroleukemia cell line.
Iwatsuki K; Endo T; Misawa H; Yokouchi M; Matsumoto A; Ohtsubo M; Mori KJ; Yoshimura A
J Biol Chem; 1997 Mar; 272(13):8149-52. PubMed ID: 9079629
[TBL] [Abstract][Full Text] [Related]
45. Advances in understanding the pathogenesis of primary familial and congenital polycythaemia.
Huang LJ; Shen YM; Bulut GB
Br J Haematol; 2010 Mar; 148(6):844-52. PubMed ID: 20096014
[TBL] [Abstract][Full Text] [Related]
46. Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways.
Wakao H; Harada N; Kitamura T; Mui AL; Miyajima A
EMBO J; 1995 Jun; 14(11):2527-35. PubMed ID: 7781605
[TBL] [Abstract][Full Text] [Related]
47. Hematopoietic cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells.
Sharlow ER; Pacifici R; Crouse J; Batac J; Todokoro K; Wojchowski DM
Blood; 1997 Sep; 90(6):2175-87. PubMed ID: 9310468
[TBL] [Abstract][Full Text] [Related]
48. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor.
Chen J; Jacobs-Helber SM; Barber DL; Sawyer ST
Exp Cell Res; 2004 Aug; 298(1):155-66. PubMed ID: 15242770
[TBL] [Abstract][Full Text] [Related]
49. Dynamic ligand modulation of EPO receptor pools, and dysregulation by polycythemia-associated EPOR alleles.
Singh S; Verma R; Pradeep A; Leu K; Mortensen RB; Young PR; Oyasu M; Schatz PJ; Green JM; Wojchowski DM
PLoS One; 2012; 7(1):e29064. PubMed ID: 22253704
[TBL] [Abstract][Full Text] [Related]
50. Familial erythrocytosis associated with a short deletion in the erythropoietin receptor gene.
Arcasoy MO; Degar BA; Harris KW; Forget BG
Blood; 1997 Jun; 89(12):4628-35. PubMed ID: 9192789
[TBL] [Abstract][Full Text] [Related]
51. Activation of the JAK1-STAT5 pathway by binding of the Friend virus gp55 glycoprotein to the erythropoietin receptor.
Yamamura Y; Senda H; Noda M; Ikawa Y
Leukemia; 1997 Apr; 11 Suppl 3():432-4. PubMed ID: 9209415
[TBL] [Abstract][Full Text] [Related]
52. CrkL is recruited through its SH2 domain to the erythropoietin receptor and plays a role in Lyn-mediated receptor signaling.
Arai A; Kanda E; Nosaka Y; Miyasaka N; Miura O
J Biol Chem; 2001 Aug; 276(35):33282-90. PubMed ID: 11443118
[TBL] [Abstract][Full Text] [Related]
53. A novel mutation in the erythropoietin receptor gene is associated with familial erythrocytosis.
Arcasoy MO; Karayal AF; Segal HM; Sinning JG; Forget BG
Blood; 2002 Apr; 99(8):3066-9. PubMed ID: 11929803
[TBL] [Abstract][Full Text] [Related]
54. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
[TBL] [Abstract][Full Text] [Related]
55. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation.
Damen JE; Wakao H; Miyajima A; Krosl J; Humphries RK; Cutler RL; Krystal G
EMBO J; 1995 Nov; 14(22):5557-68. PubMed ID: 8521813
[TBL] [Abstract][Full Text] [Related]
56. Cytokine signals through STAT3 promote expression of granulocyte secondary granule proteins in 32D cells.
Wang L; Arcasoy MO; Watowich SS; Forget BG
Exp Hematol; 2005 Mar; 33(3):308-17. PubMed ID: 15730854
[TBL] [Abstract][Full Text] [Related]
57. Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor.
Miura Y; Miura O; Ihle JN; Aoki N
J Biol Chem; 1994 Nov; 269(47):29962-9. PubMed ID: 7961995
[TBL] [Abstract][Full Text] [Related]
58. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2.
Kilic U; Kilic E; Soliz J; Bassetti CI; Gassmann M; Hermann DM
FASEB J; 2005 Feb; 19(2):249-51. PubMed ID: 15556972
[TBL] [Abstract][Full Text] [Related]
59. The erythropoietin receptor gene is not linked with the polycythemia phenotype in a family with autosomal dominant primary polycythemia.
Kralovics R; Sokol L; Broxson EH; Prchal JT
Proc Assoc Am Physicians; 1997 Nov; 109(6):580-5. PubMed ID: 9394420
[TBL] [Abstract][Full Text] [Related]
60. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin.
Witthuhn BA; Quelle FW; Silvennoinen O; Yi T; Tang B; Miura O; Ihle JN
Cell; 1993 Jul; 74(2):227-36. PubMed ID: 8343951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
